Krishnaswamy Yeleswaram, Chief Development Officer at Rapport Therapeutics, Inc. (RAPP), sold 50,160 shares at $50.00 ($2.5M) on 2026-08-24, disclosed to the SEC on 2026-08-26.
Scheduled sale ($2.5M) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 13,160 | $658K | 26.0% |
| 2 | $50.31 | 20,799 | $1.0M | 41.3% |
| 3 | $51.06 | 16,201 | $827K | 32.7% |
| Total | $50.47 avg | 50,160 | $2.5M | 100% |
| Filing → |
| RAPP | SELL | 2026-04-14 | $696K | — | Filing → |
| RAPP | SELL | 2026-04-09 | $13K | — | Filing → |
| RAPP | SELL | 2026-03-26 | $607K | — | Filing → |